Timeline
Pharma
Physiomics appoints Stewart Williams as consultant
The Premarket Brief: Marston's reaffirms FY2026 guidance on margin gains, Angling Direct, Greggs, Wickes, Novo Nordisk, Wizz Air
Novo Nordisk says early responders to Wegovy 7.2 mg lose 27.7% at 72 weeks
Poolbeg Pharma wins Canadian patent for POLB 001 CRS use
GSK strikes exclusive China collab to roll out bepirovirsen
Avacta says pre|CISION releases payload faster and more selectively than approved ADCs
Abingdon Health named CDMO and manufacturer for 4TEEN4's diagnostic
Health & Bio Today: BSF Enterprise auctions T-Rex leather at Drouot, genedrive, ImmuPharma, Creo Medical, hVIVO
Fusion Antibodies shares dip after year-end trading statement
ImmuPharma launches IND‑enabling programme for Kapiglucagon with tranScrip
Shield Therapeutics reports 54% growth in ACCRUFeR sales, but warns over impact of Medicaid changes
AstraZeneca's Truqap recommended by FDA advisory panel for a form of prostate cancer
AstraZeneca fails to win FDA advisory backing for camizestrant
Tech Today: Built Cybernetics, Visum, Weir Group, Sage, ZOO Digital
Health & Bio Today: GSK drops despite strong Q1, SkinBioTherapeutics, Solvonis, AstraZeneca, Ondine Biomedical
Tech Today: Smarter Web, Sage, MedPal AI, Shearwater, ZOO Digital, AstraZeneca, Ondine Biomedical
Solvonis to prioritise Phase 3 for lead asset
MedPal AI buys Remedi Runcorn pharmacy, adding a £10m patient book
The Premarket Brief: GSK, Lloyds, AstraZeneca, Prudential, Haleon, Ondine Biomedical, Halfords, Frasers Group, Treatt
AstraZeneca repeats 2026 guidance as Q1 revenue rises 8%
Haleon sees quarter of revenue growth driven by oral health brands
Health & Bio Today: GSK, AstraZeneca, Hemogenyx Pharmaceuticals, Genflow Biosciences
Hemogenyx Pharmaceuticals shares fall after £3m fundraising
Genflow Biosciences shares higher as 'tier-1' talks advance
Quantum Data Energy starts Bordesley construction as £1m placing backs pipeline
GSK wins FDA priority review and breakthrough tag for bepirovirsen
AstraZeneca wins US approval for Breztri in asthma
Health & Bio Today: GSK's efimosfermin wins FDA Breakthrough and EMA PRIME status, PureTech Health, Ondine Biomedical, AstraZeneca
Seaport Therapeutics appoints Intra‑Cellular founder Sharon Mates to board
GSK's efimosfermin sees FDA Breakthrough
AstraZeneca wins US approval for once-weekly Saphnelo self-injection
GSK subsidiary TESARO has anticipatory breach claim dismissed by Delaware court
The Premarket Brief: ECR Minerals, Ondine Biomedical, 88 Energy, Pathos Communications, Beowulf Mining
Shield Therapeutics partner MEDLEAP confirms first patient enrollment in Japan Phase II for ACCRUFeR
Hikma reiterates full-year 2026 guidance after encouraging start to the year
PureTech posts positive Phase 1b LYT-200 data and will prioritise relapsed/refractory high‑risk MDS
Helical advances lettings and de‑risks pipeline ahead of full‑year results
hVIVO to run pivotal Phase III whooping cough human challenge trial for ILiAD
Avacta demonstrates AVA6103 outdelivers Enhertu and reveals dual‑payload in vivo data
CRISM Therapeutics shows 58% tumour reduction with Docetaxel-ChemoSeed
AstraZeneca's Ultomiris meets primary endpoint in IgAN Phase III
TheraCryf manufactures clinical-grade Ox‑1
The Premarket Brief: GSK wins China approval for Blenrep in myeloma, Renishaw, Mulberry, Plus500, Supreme, Nanoco, ATOME, Smarter Web Company, Angus Energy
AstraZeneca reports tozorakimab cuts COPD exacerbations in Phase III MIRANDA
CelLBxHealth partners with The Royal Marsden on 200‑patient CTC study
GSK wins China approval for Blenrep in 2L+ multiple myeloma
Poolbeg Pharma says TOPICAL trial gets greenlight
GSK completes acquisition of 35Pharma for $950m
hVIVO revenue slides, strategy pivot offsets market hit
More in Healthcare
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.
Companies in Pharma
- AstraZeneca AZN
- GSK LSE:GSK
- Bsf Enterprise LSE:BSFA
- Seagate Technology AIM:STX
- Solvonis Therapeutics LSE:SVNS
- Eco Animal Health AIM:EAH
- Novo Nordisk NVO
- Beximco Pharmaceuticals LSE:BXP
- Nuformix LSE:NFX
- Hikma Pharmaceuticals LSE:HIK
- Novo Nordisk A/S 0QIU
- Avere Therapeutics Nasdaq:AVRX
- Eli Lilly NYSE:LLY
- Kailera Nasdaq:KLRA